The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area)

Pediatric Blood and Cancer

Volumn 63, Issue 1, 2016, Pages 168-170

  Grosse, Regine ^a   Lukacs, Zoltan ^a   Cobos, Paulina Nieves ^a   Oyen, Florian ^a   Ehmen, Christa ^b   Muntau, Birgit ^b   Timmann, Christian ^b   Noack, Bernd ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

Hemoglobin; Hemoglobinopathies; Red blood cell disorders; Sickle cell anemia; Sickle cell disease

Indexed keywords

ANCESTRY GROUP; ARTICLE; BLOOD GROUP DUFFY SYSTEM; CHILD; GENETIC SCREENING; GENOTYPE; GERMANY; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; SICKLE CELL ANEMIA; URBAN AREA; ANEMIA, SICKLE CELL; NEWBORN; PROCEDURES;

ANEMIA, SICKLE CELL; GENOTYPE; GERMANY; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PREVALENCE;

EID: 84951568462     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25706     Document Type: Article

References (19)

1. Quinn C, Rogers Z, McCavit T, Buchanan G. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115:3452-3477.
2. Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988; 81:749-755.
3. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, Diamond S, Holbrook CT, Gill FM, Ritchey K, Falletta JM. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med 1986; 314:1593-1599.
4. Piel FB, Tatem AJ, Huang Z, Gupta S, Williams TN, Weatherall DJ. Global migration and the changing distribution of sickle haemoglobin: A quantitative study of temporal trends between 1960 and 2000. Lancet Glob Health 2014; 2:e80-e89.
5. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Temperley WH, Williams TN. Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates. Lancet 2013; 381:142-151.
6. Streetly A, Latinovic R, Hall K, Henthorn J. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: Screening results for 2005-7. J Clin Pathol 2009; 62:26-30.
7. Bardakdjian-Michau J, Bahuau M, Hurtrel D, Godart C, Riou J, Mathis M, Goossens M. Neonatal screening for sickle cell disease in France. J Clin Pathol 2009; 62:31-33.
8. Bouva M, Mohrmann K, Brinkman H, Kemper-Proper EA, Elvers B, Loeber JG, Verheul FE, Giordano PC. Implementing neonatal screening for haemoglobinopathies in the Netherlands. J Med Screen 2010; 17:58-65.
9. Lobitz S, Frömmel C, Brose A, Klein J, Blankenstein O. Incidence of sickle cell disease in an unselected cohort of neonates born in Berlin, Germany. Eur J Hum Genet 2014; 22:1-3.
10. Nationaler Screeningreport 2012. Deutsche Gesellschaft für Neugeborenenscreening 2012. http://www.screening-dgns.de/screeningregister-2i.htm Accessed 15 January 2015.
11. Änderung der Richtlinien des Bundesausschusses der Ärzte und Krankenkassen über die Früherkennung von Krankheiten bei Kindern bis zur Vollendung des 6. Lebensjahres (Kinder-Richtlinien) zur Einführung des erweiterten Neugeborenen-Screenings. BAnz 2005;60:4833.
12. Herrmann MG, Dobrowolski SF, Wittwer CT. Rapid beta-globin genotyping by multiplexing probe melting temperature and color. Clin Chem 2000; 46:425-428.
13. Rund D, Cohne T, Filon D, Dowling CE, Warrens TC, Barak I, Rachmilewitz E, Kazazian HH, Jr., Oppenheim A. Evolution of a genetic disease in an ethnic isolate: ß-Thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci USA 1991; 88:310-314.
14. Howe RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Ménard D, Williams TN, Weatherall DJ, Hay SI. The global distribution of the Duffy blood group. Nat Commun 2011; 2:1-10.
15. Behörde für Gesundheit und Verbraucherschutz, Hamburg, 2014. http://www.hamburg.de/pressearchiv. Accessed 15 January 2015.
16. Piel FB, Howes RE, Patil AP, Nyangiri OA, Gething PW, Bhatt S, Williams TN, Weatherall DJ, Hay SI. The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep 2013; 3:1671.
17. Venturelli D, Lodi M, Palazzi G, Bergonzini G, Doretto G, Zini A, Monica C, Cano MC, Ilaria M, Montagnani G, Paolucci P. Sickle cell disease in areas of immigration of high-risk populations: A low cost and reproducible method of screening in northern Italy. Blood Transfus 2014; 12:346-351.
18. Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. Screening for sickle cell disease and thalassaemia: A systematic review with supplementary research. Health Technol Assess 2000; 4:1-99.
19. Robert Koch Institute, Berlin, 2012. http://www.rki.de/DE/Content/InfAZ/H/HIVAIDS/Studien/MiSSA/Pilotstudie_Mapping.pdf. Accessed 17. April 2015.